Post-operative ileus (POI) is an impairment of gastrointestinal (GI) motility that inevitably occurs after abdominal surgery. The main symptoms of this disease include nausea and vomiting, bloating, and the inability to eat orally due to delayed passage of the GI tract. POI is one of the main reasons for slowing patients’ recovery and increasing the length of hospital stay after surgery.1 In addition, the economic burden of treatment for patients due to POI is also very large. According to data from the United States, hospitalization for coded POI was substantially more costly and longer than hospitalization for non-coded POI. Total annual costs attributed to managing POI were $1.46 billion.2
At least 3 major mechanisms are suggested to be involved in the development of POI; neurogenic, inflammatory, and pharmacological mechanisms.3 Splanchnic, rather than vagal afferents, are predominantly activated during abdominal surgery and lead to decreased peristalsis during and shortly after (up to 3 hours) the operation,4 and other neural pathways are activated during abdominal surgery, according to the degree of pain of the nociceptive stimulus. Surgical manipulation of the intestine also activated macrophages to secrete inflammatory mediators, including nitric oxide, prostaglandins, and reactive oxygen intermediates.5,6 Also, this intestinal inflammation caused by bowel manipulation results in primary afferent activation, initiating subsequent inhibitory motor reflexes to the gut, and leading to post-operative intestinal gut dysfunction.7 Lastly, intake of opioids as analgesics can complicate and prolong POI.8
In this issue of the
For sure, evaluation of NLR is an effective method for predicting overall and disease-free survival in gastric cancer patients submitted to curative resection.10 A high NLR reflects both strengthened neutrophil-induced inflammatory response and weakened lymphocyte-mediated antibacterial response of cancer patients, and NLR is a more objective indicator of a patient’s condition than CRP in this study. However, in most studies of CRP and NLR for predicting the prognosis in cancer patients, they are independent factors for the survival of cancer patients, and their role in predicting tumor response and survival is more enhanced when used in combination.11,12 If these 2 factors were analyzed together in this study, it would have been a more meaningful indicator.
As the author said, this study had several limiting factors. These include its retrospective design and neglecting narcotic drug use. In addition, clinical factors such as whether there were other infectious diseases such as pneumonia and how severe the pain was were not considered. Also, factors such as operation methods, time, and post-operative complications were not included for analysis. Nevertheless, this is the first study to study the usefulness of CRP and NLR for predicting post-operative ileus in gastric cancer patients, and these results can be used meaningfully in treating patients.
Article: Peri-operative inflammatory marker as a predictive factor for prolonged post-operative ileus after gastrectomy for gastric cancer
Kim Y, Kim YM, Kim JH, Youn YH, Kim JW, Park H